S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
MarketBeat Week in Review – 4/15 - 4/19
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
Moscow says 50 Ukrainian drones shot down as attacks spark fires at Russian power stations
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market

Mangoceuticals (MGRX) Institutional Ownership

$0.29
-0.01 (-3.29%)
(As of 04/19/2024 ET)

Institutional Ownership Changes (13F Filings) for Mangoceuticals (NASDAQ:MGRX)

Current
Institutional Ownership
Percentage
56.72%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$113.64K
Number of
Institutional Sellers
(last 12 months)
0
Get MGRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mangoceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Mangoceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/8/2023Colonial River Wealth Management LLC36,100$66K0.0%N/A0.216%
7/28/2023Independent Advisor Alliance26,000$48K0.0%N/A0.162%
(Data available from 1/1/2016 forward)

MGRX Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of MGRX shares?

During the previous two years, the following institutional investors and hedge funds held shares of Mangoceuticals shares: Colonial River Wealth Management LLC ($66K), Independent Advisor Alliance ($48K).Learn more on MGRX's institutional investors.

What percentage of Mangoceuticals stock is owned by institutional investors?

56.72% of Mangoceuticals stock is owned by institutional investors. Learn more on MGRX's institutional investor holdings.

Which institutional investors have been buying Mangoceuticals stock?

The following institutional investors have purchased Mangoceuticals stock in the last 24 months: Colonial River Wealth Management LLC ($36.10K), and Independent Advisor Alliance ($26K).

How much institutional buying is happening at Mangoceuticals?

Institutional investors have bought a total of 62,100 shares in the last 24 months. This purchase volume represents approximately $113.64K in transactions.


This page (NASDAQ:MGRX) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners